Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2016 - 2022)

Alaunos Therapeutics (TCRT) has disclosed Other Accumulated Expenses for 9 consecutive years, with $169000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other Accumulated Expenses rose 1.2% year-over-year to $169000.0, compared with a TTM value of $169000.0 through Dec 2022, up 1.2%, and an annual FY2022 reading of $169000.0, up 1.2% over the prior year.
  • Other Accumulated Expenses was $169000.0 for Q4 2022 at Alaunos Therapeutics, up from $167000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $169000.0 in Q4 2022 and bottomed at $167000.0 in Q4 2021.